The effect of sildenafil and metformin on sexual functio

Phase 3

Recruiting

• Conditions: polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20160524028038N16
• Lead Sponsor: Bandare-abbas University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 108

Inclusion Criteria

Patients aged 18 to 45 years
Body mass index 19-25
Confirmation of polycystic ovary syndrome based on the Rotterdam criteria

Exclusion Criteria

Patients who do not want to cooperate.
Sildenafil sensitivity and intolerance to side effects (hot flashes, vision disorders, severe drop in blood pressure and hearing disorders)
pregnancy
Taking ocp or ovulation stimulation drugs
Existence of severe mental conditions since 6 months before the research, which has an adverse effect on the patient's quality of life
Suffering from a severe degree of depression and anxiety according to the depression and anxiety questionnaire based on the Beck depression and anxiety questionnaire
Current use of psychiatric medications
Language or cognitive problems preventing the patient from completing the questionnaire
smoking
Current use of drugs affecting sexual performance
Previous diagnosis of an organic cause for sexual dysfunction by an experienced physician
Taking vasodilator drugs and drugs that interact with metformin, silde.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual function. Timepoint: Before the intervention and three after the intervention. Method of measurement: sexual function questionnaire.